Another important finding of our study was the distinguishable profiles and trajectories of cognitive impairment among both tau and atrophy clusters, supporting the neuropathological heterogeneity in AD10, in line with the previous multimodal imaging studies36 and neuropathological analyses37 on atypical AD. This evidence concerns the gene MAPT and Alzheimer disease.